AstraZeneca has joined the ranks of pharma companies seeking to bring drugs targeting lipoprotein(a) to market, paying $100 million upfront for rights to a drug developed by CSPC Pharmaceutical.
Hosted on MSN8mon
Moderna rival CSPC cleared to study RSV shot in ChinaShijiazhuang-based CSPC (OTCPK:CHJTF) said that SYS6016 has already undergone preclinical trials, neutralizing both RSV-A and RSV-B strains of the virus with a favorable safety profile.
PETALING JAYA: Pharmaniaga Bhd ’s wholly-owned subsidiary Pharmaniaga LifeScience Sdn Bhd has signed a memorandum of understanding (MoU) with CSPC Holdings Co Ltd of China to collaborate in the ...
KUALA LUMPUR: Pharmaniaga Bhd 's wholly-owned subsidiary Pharmaniaga LifeScience Sdn Bhd has entered into a memorandum of understanding (MOU) with CSPC Holdings Co Ltd to explore a collaboration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results